在患有先天性心脏病的成年人中使用机械循环支装置
Deen L Garba1, Susan Joseph2, Ari Cedars1
1Johns Hopkins Hospital, Baltimore, Maryland.
Current opinion in organ transplantation
|August 8, 2024
概括
机械循环支持 (MCS) 为患有先天性心脏病 (ACHD) 的成年人提供了一个至关重要的选择,他们面临末期心力衰竭. 这项技术可以改善这种不断增长的患者群体的移植候选人和结果.
科学领域:
- 心脏病学 心脏病学
- 移植医学 移植医学
- 遗传性心脏病是一种先天性心脏病.
背景情况:
- 机械循环支持 (MCS) 对等待移植的末期心力衰竭患者至关重要.
- 它在患有终期心力衰竭的成人先天性心脏病 (ACHD) 中的应用仍然很少见.
- 本综述侧重于日益增长的患有慢性心脏病和循环衰竭风险的ACHD人群.
研究的目的:
- 审查目前关于MCS技术在末期心力衰竭的ACHD患者的数据.
- 突出MCS在这个特定人群中的潜在好处.
- 为了向临床实践提供有关MCS在ACHD中的使用的信息.
主要方法:
- 审查现有的文献和有关MCS在ACHD患者的数据.
- 分析与临时和持久MCS设备相关的结果.
- 检查新器官分配政策的影响.
主要成果:
- 在ACHD中,MCS越来越多地被用作移植的桥梁.
- 新的器官列表系统可能有利于暂时的MCS,改善稳定性并减少等待时间.
- 无论是暂时的还是持久的MCS都可以提高移植候选性和移植后的结果.
结论:
- 持久和暂时的MCS可以显著改善ACHD患者的移植机会.
- 这些设备有可能提高ACHD的整体移植结果.
- 在这个人群中,MCS的进一步研究和应用是有必要的.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.6K
相关概念视频
Heart Failure V: Medical Management
641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
